The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...

The CDC's vaccine committee will convene for a two-day meeting this week to consider recommendations on vaccines, including ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

The company says its vaccine is on track for full approval, following delay. Novavax shares soared following the announcement ...

Novavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...

Just 13 percent of children have gotten the latest Covid shot, according to the most recent CDC data. And after Republicans, ...

The Novavax COVID-19 vaccine is set to finally receive full approval from the FDA. The agency said Novavax must collect more ...

The cabinet's decision to pause vaccine purchases followed a recommendation by vaccine opponent Peter Kotlar, the ...

When COVID-19 first emerged, the U.S., under President Donald Trump, made an urgent bet on vaccines — and it paid off ...

A controversial Nigerian cleric, Chris Oyakhilome, has claimed without evidence that Pope Francis died from the effects of ...